Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Shenyang
Clinical trial register · China

Clinical Trials in Shenyang, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Shenyang 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Shengjing Hospital47 General Hospital of Shenyang Military Region33 First Hospital of China Medical University19 AstraZeneca13 China Medical University, China11 Shenyang Northern Hospital10 Sanofi9 AbbVie8 Novartis Pharmaceuticals8 Janssen Research & Development, LLC6 Shenyang Medical College6 BeOne Medicines6 Hoffmann-La Roche5 GlaxoSmithKline4 Changchun GeneScience Pharmaceutical Co., Ltd.4 Caigang Liu4 Liaoning Cancer Hospital & Institute4 Jiangsu Simcere Pharmaceutical Co., Ltd.4 Second Affiliated Hospital, Zhejiang University, School of Medicine4 Second Xiangya Hospital of Central South University3 Hui-Sheng Chen3 Innovent Biologics (Suzhou) Co. Ltd.3 Yunpeng Liu3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.3 Sichuan Baili Pharmaceutical Co., Ltd.3 Shanghai Zhongshan Hospital3 Ruijin Hospital3 Fudan University3 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.3 Yu Shi3 Abbisko Therapeutics Co, Ltd3 Shanghai Junshi Bioscience Co., Ltd.2 Takeda2 Peking University2 Beijing Biostar Pharmaceuticals Co., Ltd.2 Jiangsu HengRui Medicine Co., Ltd.2 The Fourth Affiliated Hospital of China Medical University2 Xiujuan Qu2 Actelion2 Tongji Hospital2 Shanghai Shenqi Medical Technology Co., Ltd2 Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences2 Chuansheng Zhao2 Bristol-Myers Squibb2 Xijing Hospital of Digestive Diseases2 Tang-Du Hospital2 Suzhou Suncadia Biopharmaceuticals Co., Ltd.2 Wigen Biomedicine Technology (Shanghai) Co., Ltd.2 MediLink Therapeutics (Suzhou) Co., Ltd.2 Huashan Hospital2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences2 Nanjing Leads Biolabs Co.,Ltd2 Pfizer2 China-Japan Friendship Hospital2 Yi Tian1 Cytokinetics1 Sichuan University1 JiaRay Group1 Changhai Hospital1 TJ Biopharma Co., Ltd.1 Biocells (Beijing) Biotech Co.,Ltd1 Guangdong Hengrui Pharmaceutical Co., Ltd1 Jiangsu Genscend Biopharmaceutical Co., Ltd1 Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.1 Gracell Biotechnologies (Shanghai) Co., Ltd.1 Shanghai Weihe Medical Laboratory Co., Ltd.1 Zhuhai Beihai Biotech Co., Ltd1 He Eye Hospital1 Jacobio Pharmaceuticals Co., Ltd.1 Shanghai Chest Hospital1 Yufan Wang1 Xingshun Qi1 Shanghai Huaota Biopharmaceutical Co., Ltd.1 GeneCradle Inc1 FutureGen Biopharmaceutical (Beijing) Co., Ltd1 Nanfang Hospital, Southern Medical University1 Shanghai Best-Link Bioscience, LLC1 Shenzhen Ionova Life Sciences Co., Ltd.1 BeiGene1 Tianjin Medical University Cancer Institute and Hospital1 Kunming Pharmaceuticals, Inc.1 Avenzo Therapeutics, Inc.1 Ton-Bridge Medical Tech. Co., Ltd1 Pulnovo Medical (Wuxi) Co., Ltd.1 Abivax S.A.1 Hutchmed1 Eye & ENT Hospital of Fudan University1 Lifetech Scientific (Shenzhen) Co., Ltd.1 Beijing Hospital1 DualityBio Inc.1 PharmaEssentia1 Celgene1 Liaoning Chengda Biotechnology CO., LTD1 argenx1 Qilu Pharmaceutical Co., Ltd.1 ShenZhen Cell Valley1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1 magAssist, Inc.1 The Second Affiliated Hospital of Dalian Medical University1 Sun Yat-sen University1 Tianjin Institute of Pharmaceutical Research Co., Ltd1 Beijing Chao Yang Hospital1 Genfleet Therapeutics (Shanghai) Inc.1 Zenith Epigenetics1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1 Excyte Biopharma Ltd1 Sichuan Huiyu Pharmaceutical Co., Ltd1 Gilead Sciences1 Jun Wei1 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.1 Akeso1 Chinese Academy of Sciences1 Queen's University, Belfast1 Institute of Hematology & Blood Diseases Hospital, China1 E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.1 Tarapeutics Science Inc.1 First People's Hospital of Shenyang1 Jilin University1 European Myeloma Network B.V.1 Haisco Pharmaceutical Group Co., Ltd.1 Shanghai SciBrunch Therapeutics Co., Ltd.1 Shanghai Mabgeek Biotech.Co.Ltd1 Chinese SLE Treatment And Research Group1 Jianbin Bi1 Peking University Hospital of Stomatology1 Ganzhou Hemay Pharmaceutical Co., Ltd1 Peking University Third Hospital1 Prime Gene Therapeutics Co., Ltd.1 Hangzhou Sumgen Biotech Co., Ltd.1 Shanghai Pulmonary Hospital, Shanghai, China1 Obstetrics & Gynecology Hospital of Fudan University1 Servier Bio-Innovation LLC1 Eli Lilly and Company1 CSPC Megalith Biopharmaceutical Co.,Ltd.1 SUNHO(China)BioPharmaceutical CO., Ltd.1 Shanghai Pushi Medical Science Co. Ltd1 Nanjing First Hospital, Nanjing Medical University1 Boehringer Ingelheim1 Xuanwu Hospital, Beijing1 Chengdu New Radiomedicine Technology Co. LTD.1 Children's Hospital of Philadelphia1 Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.1 Oneness Biotech Co., Ltd.1 Han Ying1 Hangzhou GluBio Pharmaceutical Co., Ltd.1 Haibo Shao1 Ascentawits Pharmaceuticals, Ltd1 Jie Liang1 Huabo Biopharm Co., Ltd.1 Candid Therapeutics1 Hepatopancreatobiliary Surgery Institute of Gansu Province1 Innatus Therapeutics (Shanghai) Co., Ltd.1 Medtronic Cardiac Ablation Solutions1 Xueyan Zhao1 I-Mab Biopharma US Limited1 RemeGen Co., Ltd.1 Mirati Therapeutics Inc.1 Peking University People's Hospital1 NextCure, Inc.1 Jingdong Zhang1 Jiangsu vcare pharmaceutical technology co., LTD1 XueMei Guo1 Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.1 Shanghai Jiao Tong University School of Medicine1 Beijing Tiantan Hospital1 Lepu Biopharma Co., Ltd.1 Amgen1 Affiliated Hospital of Liaoning University of Traditional Chinese Medicine1 Zhao Minghui1 Shanghai Bluesail Boyuan Medical Technology Co., Ltd.1 Sinovac Biotech Co., Ltd1 Jianyi Li1 Beijing Bio-Targeting Therapeutics Technology Co., Ltd1 Pai Pang1 Clear sponsor filter
Site location
Shenyang2
All 1 locations
Target enrolment
to

Trials with a site in Shenyang

2 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Chuansheng Zhao
Phase 4
80
Shenyang
2026-03-02
Not yet open
Chuansheng Zhao
Phase 3
344
Shenyang
2026-03-01
Rows per page Showing 1–2 of 2
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/shenyang

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2 of those studies with a site in Shenyang that also match the filters currently applied.

How many clinical trials are recruiting in Shenyang?

1 of the 2 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Shenyang), 2 studies
PhaseStudiesRecruitingShare
Phase 31050%
Phase 41150%

Most active sponsors

Lead sponsors with the most studies (Shenyang)
Lead sponsorStudiesRecruiting
Chuansheng Zhao21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.